Updated On: 01 December, 2020 08:45 PM IST | Mumbai | IANS
sputnik V was developed by the Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Healthcare Ministry

Picture used for representational purpose only
Sputnik V, the first registered Covid-19 vaccine from Russia arrived in India on Tuesday for clinical trials. Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories today initiated the clinical trials of the vaccine, the Indian pharma company said.
Russia became the first country to register the world's first Covid-19 vaccine on August 11. Sputnik V was developed by the Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Healthcare Ministry.